Picard Medical is trading 5.7% down at $3.97, with no verified company-specific announcement or overnight catalyst identified for September 22.
- Fell 17.13% on September 21, extending a sharp seven-day decline.
- Previously reported NYSE American compliance-plan acceptance is not new.
- Broader markets are mixed rather than materially weaker, leaving the pre-market decline without a confirmed explanation.